Current Edition

Upcoming Events

Advertisement

Non-clinical Evaluations for Anti-cancer Drugs with ICH S9 Guideline Q&A – What the Industry Needs to Know
Volume 2 Issue 1

Non-clinical Evaluations for Anti-cancer Drugs with ICH S9 Guideline Q&A – What the Industry Needs to Know

The ICH S9 Guideline Q&A document – published in June 2018 – is designed to clarify some of the most common challenges experienced across the industry when implem...
Continue Reading →
Raising Organisational Fluency in Real-world Evidence
Volume 2 Issue 1

Raising Organisational Fluency in Real-world Evidence

The planet is currently experiencing global healthcare crises that affect huge populations. From diabetes to Alzheimer’s to mental health conditions, we still lack re...
Continue Reading →
Applying Standardised NMR Spectroscopy to Research Human Diseases
Volume 2 Issue 1

Applying Standardised NMR Spectroscopy to Research Human Diseases

In this article Professor Matthias Nauck of Universitätsmedizin Greifswald and Roland Leiminger of Bruker BioSpin examine the importance of Biobanks and how they are ...
Continue Reading →
Alzheimer’s Disease: The Way Forward
Volume 2 Issue 1

Alzheimer’s Disease: The Way Forward

Emily Burke at Biotech Primer examines Alzheimer’s disease (AD) and how it ranks as one of the toughest nuts to crack within drug discovery and development. Current t...
Continue Reading →
Artificial Intelligence Expands the Destiny of DNA Analysis
Volume 2 Issue 1

Artificial Intelligence Expands the Destiny of DNA Analysis

DNA is the code that has defined humanity for millennia. Until more recently, DNA has determined destiny. There was no escaping its design and code for individuals. I...
Continue Reading →
Diagnosis Still Poses the Biggest Challenge in the AIDS Battle
Volume 2 Issue 1

Diagnosis Still Poses the Biggest Challenge in the AIDS Battle

Significant progress has been made in the AIDS response since 1988, however ensuring a swift and accurate diagnosis accessible to everyone is still a significant barr...
Continue Reading →
Clinical and Investigator-initiated Trials’ Effect on MSL Responsibilities
Volume 2 Issue 1

Clinical and Investigator-initiated Trials’ Effect on MSL Responsibilities

Among the many responsibilities assigned to medical science liaisons (MSLs) is facilitating company collaboration with thought leaders on clinical trial work. Accordi...
Continue Reading →
Antibodies Exploration Thanks to Label-free Surface Plasmon Resonance Imaging Technology
Volume 2 Issue 1

Antibodies Exploration Thanks to Label-free Surface Plasmon Resonance Imaging Technology

Surface plasmon resonance imaging allows the study of molecules binding in label-free and real-time conditions. The power of the technique comes from its singularitie...
Continue Reading →
The Effect of Insulin on Cell Growth and Virus Production
Volume 2 Issue 1

The Effect of Insulin on Cell Growth and Virus Production

This article by Aziza Manceur from National Research Council Canada describes a project whose goal was to test insulin as a booster for cell growth and virus producti...
Continue Reading →
The Drug Delivery Innovation League Table – Germany and France Lead the Way in Europe
Volume 2 Issue 1

The Drug Delivery Innovation League Table – Germany and France Lead the Way in Europe

The last two years have been some of the most remarkable years in pharmaceutical history. There were 46 FDA approvals in 2017, and this year we have received a record...
Continue Reading →